AAAAAA
Results:
1-25
|
Results: 25
Authors:
CURRAN D
Citation: D. Curran, BASE-LINE QUALITY-OF-LIFE OF PATIENTS WITH ADVANCED PROSTATE-CANCER (VOL 33, PG 1809, 1997), European journal of cancer, 34(6), 1998, pp. 945-945
Authors:
CURRAN D
VANDONGEN JP
AARONSON NK
KIEBERT G
FENTIMAN IS
MIGNOLET F
BARTELINK H
Citation: D. Curran et al., QUALITY-OF-LIFE OF EARLY-STAGE BREAST-CANCER PATIENTS TREATED WITH RADICAL-MASTECTOMY OR BREAST-CONSERVING PROCEDURES - RESULTS OF EORTC TRIAL-10801, European journal of cancer, 34(3), 1998, pp. 307-314
Authors:
CURRAN D
DEHAES JCJM
AARONSON NK
TAAT C
VANZIJL K
MIGNOLET F
FENTIMAN IS
Citation: D. Curran et al., QUALITY-OF-LIFE OF ELDERLY BREAST-CANCER PATIENTS TREATED WITH MASTECTOMY OR TUMOR-EXCISION PLUS TAMOXIFEN - RESULTS OF EORTC-TRIAL-10850, Annals of oncology, 9, 1998, pp. 18-18
Authors:
THERASSE P
MAURIAC L
WELNICKA M
BRUNING P
CUFER T
TOMIAK E
CURRAN D
RAMIREZ A
KOOPMANSCHAP M
PICCART M
Citation: P. Therasse et al., AN EORTC-NCIC-SAKK NEOADJUVANT RANDOMIZED PHASE-III STUDY COMPARING CEF (5FU, EPIRUBICIN, CYCLOPHOSPHAMIDE) VS DOSE INTENSIFIED EC-CSF (FILGRASTIM) IN LOCALLY ADVANCED BREAST-CANCER (LABC) - UPDATED RESULTS INCLUDING QUALITY-OF-LIFE(G), Annals of oncology, 9, 1998, pp. 63-63
Authors:
PICCART MJ
GREEN J
LACAVE AJ
REED N
BENEDETTIPANICI P
LENTZ MA
SELVAIS R
CURRAN D
PINEL MC
VERGOTE I
Citation: Mj. Piccart et al., OXALIPLATIN - AN ACTIVE COMPOUND IN PLATINUM PRETREATED OVARIAN-CANCER PATIENTS - FINAL RESULTS OF A RANDOMIZED PHASE-II TRIAL BY THE EORTC- GYNECOLOGICAL CANCER COOPERATIVE GROUP, Annals of oncology, 9, 1998, pp. 314-314
Authors:
GIACCONE G
SPLINTER TAW
DEBRUYNE C
KHO GS
LIANES P
VANZANDWIJK N
PENNUCCI MC
SCAGLIOTTI G
VANMEERBEECK J
VANHOESEL Q
CURRAN D
SAHMOUD T
POSTMUS PE
Citation: G. Giaccone et al., RANDOMIZED STUDY OF PACLITAXEL-CISPLATIN VERSUS CISPLATIN-TENIPOSIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 16(6), 1998, pp. 2133-2141
Authors:
CURRAN D
SAHMOUD T
THERASSE P
VANMEERBEECK J
POSTMUS PE
GIACCONE G
Citation: D. Curran et al., PROGNOSTIC FACTORS IN PATIENTS WITH PLEURAL MESOTHELIOMA - THE ON-FOR-RESEARCH-AND-TREATMENT-OF-CANCER-EXPERIENCE, Journal of clinical oncology, 16(1), 1998, pp. 145-152
Authors:
WILS J
SAHMOUD T
SOBRERO A
BLEIBERG H
AHMEDZAI S
BLAZEBY J
BLIJHAM G
CONROY T
CUNNINGHAM D
CURRAN D
DIAZRUBIO E
DUCREUX M
EVANS J
GLIMELIUS B
HUTCHINSON G
KERR D
KIEBERT G
KOHNE H
LABIANCA R
LANGENDIJK R
NITTI D
NORDLINGER B
ROUGIER P
SCHEITHAUER W
SCHMOLL HJ
VANCUTSEM E
WAGENER T
WILKE J
MARINUS A
THERASSE P
Citation: J. Wils et al., EVALUATION OF CLINICAL EFFICACY OF NEW MEDICAL TREATMENTS IN ADVANCEDCOLORECTAL-CANCER - RESULTS OF A WORKSHOP ORGANIZED BY THE EORTC GITCCG, Tumori, 84(3), 1998, pp. 335-347
Authors:
KIEBERT GM
CURRAN D
AARONSON NK
Citation: Gm. Kiebert et al., QUALITY-OF-LIFE AS AN END-POINT IN EORTC CLINICAL-TRIALS, Statistics in medicine, 17(5-7), 1998, pp. 561-569
Authors:
TROXEL AB
FAIRCLOUGH DL
CURRAN D
HAHN EA
Citation: Ab. Troxel et al., STATISTICAL-ANALYSIS OF QUALITY-OF-LIFE WITH MISSING DATA IN CANCER CLINICAL-TRIALS, Statistics in medicine, 17(5-7), 1998, pp. 653-666
Authors:
FAYERS PM
CURRAN D
MACHIN D
Citation: Pm. Fayers et al., INCOMPLETE QUALITY-OF-LIFE DATA IN RANDOMIZED TRIALS - MISSING ITEMS, Statistics in medicine, 17(5-7), 1998, pp. 679-696
Authors:
CURRAN D
MOLENBERGHS G
FAYERS PM
MACHIN D
Citation: D. Curran et al., INCOMPLETE QUALITY-OF-LIFE DATA IN RANDOMIZED TRIALS - MISSING FORMS, Statistics in medicine, 17(5-7), 1998, pp. 697-709
Authors:
CURRAN D
BACCHI M
SCHMITZ SFH
MOLENBERGHS G
SYLVESTER RJ
Citation: D. Curran et al., IDENTIFYING THE TYPES OF MISSINGNESS IN QUALITY-OF-LIFE DATA FROM CLINICAL-TRIALS, Statistics in medicine, 17(5-7), 1998, pp. 739-756
Authors:
POSTMUS PE
HAAXMAREICHE H
GREGOR A
GROEN HJM
LEWINSKI T
SCOLARD T
KIRKPATRICK A
CURRAN D
SAHMOUD T
GIACCONE G
Citation: Pe. Postmus et al., BRAIN-ONLY METASTASES OF SMALL-CELL LUNG-CANCER - EFFICACY OF WHOLE-BRAIN RADIOTHERAPY - AN EORTC PHASE-II STUDY, Radiotherapy and oncology, 46(1), 1998, pp. 29-32
Authors:
ROUGIER P
SAHMOUD T
NITTI D
CURRAN D
DOCI R
DEWAELE B
NAKAJIMA T
RAUSCHECKER H
LABIANCA R
PECTOR JC
MARSONI S
APOLONE G
LASSER P
COUVREUR ML
WILS J
Citation: P. Rougier et al., ADJUVANT PORTAL-VEIN INFUSION OF FLUOROURACIL AND HEPARIN IN COLORECTAL-CANCER - A RANDOMIZED TRIAL, Lancet, 351(9117), 1998, pp. 1677-1681
Authors:
VANDERBURG MEL
BOLIS G
BAKKER PJM
CURRAN D
SAHMOUD T
VERMORKEN JB
Citation: Mel. Vanderburg et al., PHASE-II STUDY OF WEEKLY 4'-EPIDOXORUBICIN IN PATIENTS WITH METASTATIC ADENOCARCINOMA OF THE CERVIX - AN EORTC GYNECOLOGICAL CANCER COOPERATIVE GROUP-STUDY, European journal of cancer, 33(9), 1997, pp. 1513-1515
Authors:
ROSENDAHL KI
CURRAN D
KIEBERT G
COLE B
WEEKS JC
DENIS LJ
HALL RR
Citation: Ki. Rosendahl et al., A QUALITY-ADJUSTED SURVIVAL (Q-TWIST) ANALYSIS OF EORTC TRIAL-30853 COMPARING MAXIMAL ANDROGEN BLOCKADE (MAB) WITH ORCHIECTOMY IN PATIENTS WITH METASTATIC PROSTATE-CANCER, European journal of cancer, 33, 1997, pp. 53-53
Authors:
NITTI D
WILS J
SAHMOUD T
CURRAN D
COUVREUR ML
LISE M
RAUSCHECKER H
DOSSANTOS JG
STREMMEL W
ROELOFSEN F
Citation: D. Nitti et al., FINAL RESULTS OF A PHASE-III CLINICAL-TRIAL ON ADJUVANT INTRAPORTAL INFUSION WITH HEPARIN AND 5-FLUOROURACIL (5-FU) IN RESECTABLE COLON-CANCER (EORTC GITCCG 1983-1987), European journal of cancer, 33(8), 1997, pp. 1209-1215
Authors:
FOSSA S
CURRAN D
KEUPPENS FI
KLIMENT J
ROBINSON MRG
REA LA
AARONSON NK
Citation: S. Fossa et al., AN EORTC PHASE-III STUDY COMPARING ORCHIECTOMY (CTR) AND ORCHIECTOMY PLUS MITOMYCIN-C (EXP, 15 MG M(2) INTRAVENOUSLY Q6 WKS UNTIL PROGRESSION) WITH RESPECT TO QUALITY-OF-LIFE IN PATIENTS WITH POOR-PROGNOSIS M1PROSTATE-CANCER/, European journal of cancer, 33, 1997, pp. 116-116
Authors:
PARIDAENS R
BRUNING P
KLIJN J
GAMUCCI T
BIGANZOLI L
VANVRECKEM A
BOES GH
CURRAN D
PICCART M
Citation: R. Paridaens et al., TAXOL (T) VERSUS DOXORUBICIN (D) AS FIRST-LINE CHEMOTHERAPY (CT) IN ADVANCED BREAST-CANCER (ABC) - AN EORTC RANDOMIZED STUDY WITH CROSSOVER, European journal of cancer, 33, 1997, pp. 645-645
Authors:
SAHMOUD T
GRABOWSKA E
BLIJHAM G
KOHNE CH
COUVREUR ML
CURRAN D
WILS J
Citation: T. Sahmoud et al., THE IDENTIFICATION OF HIGH-RISK PATIENTS WITH METASTATIC COLORECTAL-CANCER, European journal of cancer, 33, 1997, pp. 741-741
Authors:
CURRAN D
FOSSA S
AARONSON N
KIEBERT G
KEUPPENS E
HALL R
Citation: D. Curran et al., BASE-LINE QUALITY-OF-LIFE OF PATIENTS WITH ADVANCED PROSTATE-CANCER, European journal of cancer, 33(11), 1997, pp. 1809-1814
Authors:
POSTMUS PE
SCAGLIOTTI G
GROEN HJM
GOZZELINO F
BURGHOUTS JTW
CURRAN D
SAHMOUD T
KIRKPATRICK A
GIACCONE G
SPLINTER TAW
Citation: Pe. Postmus et al., STANDARD VERSUS ALTERNATING NON-CROSS-RESISTANT CHEMOTHERAPY IN EXTENSIVE SMALL-CELL LUNG-CANCER - AN EORTC PHASE-III TRIAL, European journal of cancer, 32A(9), 1996, pp. 1498-1503
Authors:
WAGENER DJT
HOOGENRAAD WJ
ROUGIER P
LUSINCHI A
TAAL BG
VEENHOF CHN
DEGRAEFF A
CONROY T
CURRAN D
SAHMOUD T
WILS J
Citation: Djt. Wagener et al., RESULTS OF A PHASE-II TRIAL OF EPIRUBICIN AND CISPLATIN (EP) BEFORE AND AFTER IRRADIATION AND 5-FLUOROURACIL IN LOCALLY ADVANCED PANCREATIC-CANCER - AN EORTC GITCCG STUDY, European journal of cancer, 32A(8), 1996, pp. 1310-1313
Authors:
ROUGIER P
WILS J
WILKE H
LACAVE A
VANCUTSEM E
VANHOFER U
SAHMOUD T
CURRAN D
MARINUS A
Citation: P. Rougier et al., ADVANCED GASTRIC-CANCER - COMPARISON OF FAMTX (5-FU, ADRIAMYCINE, METHOTREXATE) VERSUS ELF (ETROPOSIDE, 5-FU, LEUCOVORIN) VERSUS FUP (INFUSIONAL 5-FU PLUS CISPLATIN) - RESULTS FROM AN EORTC TRIAL OF THE GITCCGAND THE ARBEITSGEMEINSCHAFT FUR INNERE ONKOLOGIE (AIO), European journal of cancer, 31A, 1995, pp. 546-546
Risultati:
1-25
|